Immunofoco Biotechnology Co. Ltd. reported encouraging early clinical data for its CLDN18.2-targeted CAR T therapy, IMC-002, in heavily pretreated gastric and gastroesophageal junction cancer, adding ...
Investing.com -- ABPRO Holdings Inc (NASDAQ:ABP) stock rose 5.2% in Tuesday premarket trading after the company announced that the U.S. Food and Drug Administration (FDA) has cleared its ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min This Treasury-backed program's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results